Protein Science Expertise
Fusion Proteins
Expertise in developing and optimizing fusion proteins, particularly human serum albumin (HSA) fusions and Fc approaches.
PK Extension Strategies
Implementing pharmacokinetic (PK) extension strategies to enhance the efficacy and duration of biologics.
Improving Biological Activity
Techniques to increase the biological activity of therapeutic proteins and peptides.
Orally-Available Peptides
Developing and optimizing peptides for oral availability to improve patient compliance and therapeutic outcomes.
Tissue Targeting
Designing proteins and peptides to specifically target tissues, enhancing therapeutic precision and efficacy.
Blood-Brain Barrier Passage
Strategies to facilitate the passage of therapeutics across the blood-brain barrier for central nervous system diseases.
Increased Stability
Enhancing the stability of proteins and peptides to improve their shelf-life and therapeutic potential.
Immunogenicity
Minimizing immunogenicity to reduce adverse immune responses and improve the safety profile of biologics.
Bridge to CMC
Providing a seamless transition to Chemistry, Manufacturing, and Controls (CMC) by addressing formulation, stability, expression, and potency assays.
Protein Expression
Expertise in optimizing protein expression systems to achieve high yields and functional proteins for therapeutic use.
